Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$12.2M
Filings
70
Firms Hired
3
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2022
2022 · first_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Issue related to tobacco industry and tobacco products, including the pending FDA rule on flavored cigars. Issues related to the regulation of synthetic nicotine, including H.R. 2471, the Consolidated Appropriations Act of 2022.
Client expense: $410,000 · Firm income: —
Matched citations: H.R. 2471
Consolidated Appropriations Act, 2022
2022 · first_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Issue related to tobacco industry and tobacco products, including the pending FDA rule on flavored cigars. Issues related to the regulation of synthetic nicotine, including H.R. 2471, the Consolidated Appropriations Act of 2022.
Client expense: $410,000 · Firm income: —
Matched citations: H.R. 2471
Tobacco Tax Equity Act of 2021
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: H.R. 2786
Tobacco Tax Equity Act of 2021
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: H.R. 2786
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: H.R. 4356
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: H.R. 4356
Inflation Reduction Act of 2022
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: H.R. 5376
Tobacco Tax Equity Act of 2021
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: S. 1314
Tobacco Tax Equity Act of 2021
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: S. 1314
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: S. 2599
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · fourth_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $430,000 · Firm income: —
Matched citations: S. 2599
Tobacco Tax Equity Act of 2021
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 2786
Tobacco Tax Equity Act of 2021
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 2786
MOMMA’s Act
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 3407
MOMMA’s Act
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 3407
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 4356
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 4356
Inflation Reduction Act of 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 5376
Inflation Reduction Act of 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Monitored the Build Back Better Act (H.R. 5376) for implications on international trade and supply chain issues.
Client expense: $370,000 · Firm income: —
Matched citations: H.R. 5376
Tobacco Tax Equity Act of 2021
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: S. 1314
Tobacco Tax Equity Act of 2021
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: S. 1314
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: S. 2599
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
2021 · third_quarter · Firm: SWISHER INTERNATIONAL, INC. F/K/A SI GROUP CLIENT SERVICES
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. -H.R. 5376, Build Back Better Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 / S. 2599, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
Client expense: $370,000 · Firm income: —
Matched citations: S. 2599
Source: Senate LDA